iRadimed Q1 revenues up 37%; raises fiscal guidance

• iRadimed (IRMD) Q1 results: Revenues: $7.1M (+36.5%); Operating Income: $1.1M; Net Income: $0.8M; Non-GAAP Net Income: $1.2M; EPS: $0.07; Non-GAAP EPS: $0.10; CF Ops: $1.6M.
• 2018 Guidance: Revenues: $29.3M – 30.0M; EPS: $0.30 – 0.33 from $0.22 – 0.27; Non-GAAP EPS: $0.40 – 0.43 from $0.33 – 0.38.
• Q2 Guidance: Revenues: $7.2M- 7.3M; EPS: $0.07 – 0.08; Non-GAAP EPS: $0.10 – 0.11.

https://bit.ly/2rc8TKj